Regulatory News for February 23, 2022

Patient Perspective: Anxiety Follows Abrupt Departure From Clinical Trial

Determining the Most Effective Chemotherapy Regimen in Patients With Advanced KRAS-Mutated NSCLC: the NVALT22 study

Novel Targets and Therapies: KEAP1- and NFE2L2-Mutant Squamous Cell Lung Cancer

Management of Recurrences after Stereotactic Ablative Radiotherapy for Operable Early-Stage Non-Small Cell Lung Cancer

Role of Liquid Biopsy in the Clinic Growing

Need for Molecular Nursing Increasing

Targeting Angiogenesis in Mesothelioma: Insights From MAPS and RAMES

A New Standard of Care in EGFR-Positive NSCLC Unresponsive to TKIs?

The OncoKB Precision Oncology Knowledge Base: A Q&A with Dr. Debyani Chakravarty

The FDA Explained: An Interview with Dr. Harpreet Singh